EPLUS (PLUS) director granted 1,478 restricted shares under 2024 LTIP
John E. Callies, a director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of the company's common stock on 10/01/2025 under the 2024 Non-Employee Director Long Term Incentive Plan.
Rhea-AI Filing Summary
John E. Callies, a director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of the company's common stock on 10/01/2025 under the 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at no cash price ($0) and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest or be forfeited under the plan's terms. Following the grant, Mr. Callies beneficially owns 21,988 shares.
The transaction was reported on a Form 4 and signed by the reporting person. The grant increases the director's ownership stake while imposing a one-year restriction period designed to align his interests with shareholders during that term.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,478 | $0.00 | $0.00 |
Footnotes (1)
- F1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did the EPLUS (PLUS) Form 4 report disclose?
Who filed the Form 4 and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.